VAGELOS P ROY - 09 Dec 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Issuer symbol
REGN
Transactions as of
09 Dec 2022
Net transactions value
-$42,937
Form type
4
Filing time
13 Dec 2022, 15:12:47 UTC
Previous filing
01 Apr 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -23,077 -6.7% $0.000000 322,489 24 May 2022 Direct F1
transaction REGN Common Stock Tax liability $42,937 -57 -0.02% $753.28 322,432 09 Dec 2022 Direct
transaction REGN Common Stock Gift $0 -302 -0.24% $0.000000 126,704 06 Apr 2022 by CLAT
transaction REGN Common Stock Gift $0 -357 -0.28% $0.000000 126,347 05 Jul 2022 by CLAT
transaction REGN Common Stock Gift $0 -304 -0.24% $0.000000 126,043 03 Oct 2022 by CLAT
holding REGN Common Stock 2,102 09 Dec 2022 By 401(k) Plan
holding REGN Common Stock 23,461 09 Dec 2022 by Spouse as Trustee
holding REGN Common Stock 3,609 09 Dec 2022 by trust for grandch F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.